TYK2 and prostate cancer: TYK2 signaling has also been implicated in tumor-cell infiltration and metastasis in human prostate cancer patients [248], a finding recapitulated in Eμ-Myc transgenic mice, in which TYK2 deficiency reduces tumor-cell invasiveness into the liver [249].